Authors:
Ratjen, F
Comes, G
Paul, K
Posselt, HG
Wagner, TOF
Harms, K
Citation: F. Ratjen et al., Effect of continuous antistaphylococcal therapy on the rate of P-aeruginosa acquisition in patients with cystic fibrosis, PEDIAT PULM, 31(1), 2001, pp. 13-16
Citation: F. Ratjen et al., Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis, LANCET, 358(9286), 2001, pp. 983-984
Authors:
Grasemann, H
Knauer, N
Buscher, R
Hubner, K
Drazen, JM
Ratjen, F
Citation: H. Grasemann et al., Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene, AM J R CRIT, 162(6), 2000, pp. 2172-2176
Authors:
Ratjen, F
Rietschel, E
Griese, M
Ballmann, M
Kleinau, I
Doring, G
Reinhardt, D
Paul, K
Citation: F. Ratjen et al., Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function, EUR RESP J, 15(1), 2000, pp. 141-145
Citation: S. Knauer-fischer et F. Ratjen, Lipid-laden macrophages in bronchoalveolar lavage fluid as a marker for pulmonary aspiration, PEDIAT PULM, 27(6), 1999, pp. 419-422
Citation: H. Grasemann et F. Ratjen, Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis, AM J R CRIT, 159(2), 1999, pp. 684-684
Authors:
Grasemann, H
Gartig, SS
Wiesemann, HG
Teschler, H
Konietzko, N
Ratjen, F
Citation: H. Grasemann et al., Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome, EUR RESP J, 13(1), 1999, pp. 114-118
Citation: F. Ratjen et B. Tummler, Comparison of the in vitro and in vivo response to inhaled DNase in patients with cystic fibrosis, THORAX, 54(1), 1999, pp. 91-91
Authors:
Grasemann, H
Gaston, B
Fang, KZ
Paul, K
Ratjen, F
Citation: H. Grasemann et al., Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function, J PEDIAT, 135(6), 1999, pp. 770-772